$93.22
0.42% day before yesterday
Nasdaq, Nov 28, 10:00 pm CET
ISIN
US46266A1097
Symbol
IRMD

iRadimed Corp Stock price

$93.22
+13.43 16.83% 1M
+41.56 80.45% 6M
+38.22 69.49% YTD
+39.64 73.98% 1Y
+66.03 242.88% 3Y
+70.16 304.26% 5Y
+64.05 219.53% 10Y
+83.91 900.86% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.39 0.42%

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$1.1b
Net debt
positive
Cash
$56.5m
Shares outstanding
12.7m
Valuation (TTM | estimate)
P/E
56.5 | 50.2
P/S
14.7 | 14.3
EV/Sales
14.0 | 13.7
EV/FCF
81.0
P/B
12.1
Dividends
DPS
$0.68
Yield 1Y | 5Y
0.7% | 0.6%
Growth 1Y | 5Y
51.1% | -
Payout 1Y | 3Y
30.0% | 79.6%
Increased
3 Years
Financials (TTM | estimate)
Revenue
$80.5m | $82.7m
EBITDA
$25.8m | -
EBIT
$24.9m | $26.8m
Net Income
$21.2m | $23.6m
Free Cash Flow
$14.0m
Growth (TTM | estimate)
Revenue
12.9% | 12.9%
EBITDA
16.6% | -
EBIT
16.5% | 22.2%
Net Income
13.7% | 22.8%
Free Cash Flow
-18.7%
Margin (TTM | estimate)
Gross
77.1%
EBITDA
32.1% | -
EBIT
30.9%
Net
26.3% | 28.6%
Free Cash Flow
17.3%
Financial Health
Equity Ratio
88.3%
Return on Equity
22.2%
ROCE
24.4%
ROIC
39.3%
Debt/Equity
0.0
More
EPS
$1.7
FCF per Share
$1.1
Short interest
3.4%
Employees
160
Rev per Employee
$460.0k
Show more

Is iRadimed Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

iRadimed Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a iRadimed Corp forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a iRadimed Corp forecast:

Buy
88%
Hold
13%

Financial data from iRadimed Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
81 81
13% 13%
100%
- Direct Costs 18 18
13% 13%
23%
62 62
13% 13%
77%
- Selling and Administrative Expenses 34 34
24% 24%
43%
- Research and Development Expense 2.75 2.75
54% 54%
3%
26 26
17% 17%
32%
- Depreciation and Amortization 0.98 0.98
18% 18%
1%
EBIT (Operating Income) EBIT 25 25
17% 17%
31%
Net Profit 21 21
14% 14%
26%

In millions USD.

Don't miss a Thing! We will send you all news about iRadimed Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

iRadimed Corp Stock News

Neutral
GlobeNewsWire
19 days ago
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance
Neutral
The Motley Fool
20 days ago
Iradimed's CEO, President, and Chairman of the Board, Roger Susi, recently sold 5,000 shares on the open market. The transaction represented roughly 1% of his indirect holdings.
Neutral
Seeking Alpha
25 days ago
IRADIMED CORPORATION ( IRMD ) Q3 2025 Earnings Call November 3, 2025 11:00 AM EST Company Participants Roger Susi - Founder, Chairman, CEO & President John Glenn - CFO & Corporate Secretary Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Kyle Bauser - ROTH Capital Partners, LLC, Research Division Presentation Operator Welcome to the IRADIMED COR...
More iRadimed Corp News

Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices and accessories and services. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Head office United States
CEO Roger Susi
Employees 160
Founded 1992
Website www.iradimed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today